Background: The lymphocyte-to-monocyte ratio (LMR), which reflects the tumor-infiltrating
immune cell status and host immunity, has been reported as a prognostic marker in various …

Purpose Anaplastic thyroid cancer (ATC) is a rare tumor with a lethal clinical course despite
aggressive multimodal therapy. Intensity-modulated radiotherapy (IMRT) may achieve a …

Background The aim of this retrospective study was to evaluate multimodal treatments
consisting of surgery, radiotherapy (RT) and chemotherapy (CT) in metastatic anaplastic …

Background Anaplastic thyroid carcinoma (ATC) is the least common but most malignant
thyroid cancer. We aimed to examine the characteristics as well as evaluate the incidence …

Background: Anaplastic thyroid carcinoma (ATC) is a rare cancer and has a poor prognosis.
Several radiation protocols have been reported, but the results were not satisfactory …

Background/Aim: Patients with brain metastases from thyroid cancer are extremely rare. This
study evaluated clinical factors for survival following whole-brain radiotherapy (WBRT) …

Anaplastic thyroid cancer (ATC) is a very aggressive malignancy that is resistant to various
types of chemotherapy in humans. Most patients with late‑stage ATC cannot undergo …

Background/Aim: Metastatic anaplastic thyroid cancer is associated with a dismal prognosis.
We evaluated outcome and prognostic factors in patients receiving radiation to the primary …

Background/Aim: This study aimed to examine survival and surgical complications in
patients with anaplastic thyroid cancer (ATC) after multimodal treatment. Patients and …

Background In ribosome establishment and the initiation of translation, eukaryotic translation
initiation factor (eIF) 3a is a pivotal functional subunit of the eIF3 complex. In various cancer …